Johnson & Johnson (J&J) has announced an investment of over USD 1 billion in Jacksonville, Florida to strengthen its Vision operations by scaling US-based manufacturing, packaging and distribution capabilities.

The investment includes construction of a new, state-of-the-art distribution facility, alongside advanced manufacturing and packaging technologies to expand capacity and meet growing demand for the company’s ACUVUE-brand contact lenses. These enhancements further strengthen the company’s leadership in delivering high-quality, innovative eye health solutions, helping to improve sight for more than 40 million patients in the US and around the world.

Joaquin Duato, Chairman and Chief Executive Officer (CEO), Johnson & Johnson, said, “This investment reinforces our long-standing conviction that advanced manufacturing in the United States is essential to delivering innovative, high quality healthcare solutions to patients at home and around the world. By further strengthening our Vision operations in Jacksonville with next-generation manufacturing, packaging and distribution capabilities, we are enhancing the resilience of our US supply chain while helping more people see better and live better. This commitment reflects the confidence we have in our people, our technology, and our more than 40-year legacy of advancing eye health globally.”

Construction of the new facility is underway with the goal of being fully operational in 2028.

The investment builds on the company’s USD 6 billion annual economic impact in Florida and supports the continued growth of its Jacksonville operations, strengthening opportunities for the 3,500 employees based in the area while reinforcing the regional economy.